Market Overview

UPDATE: Valeant Posts Upbeat Q4 Profit

Related VRX
Are There Any Winners Left In The Biotech Space?
Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO
Energy Sector Seen as Biggest Risk to Deal Flow in 2015 (Fox Business)

Valeant Pharmaceuticals International (NYSE: VRX) posted a profit in the fourth quarter.

Valeant posted its quarterly net income of $123.8 million, or $0.36 per share, versus a year-ago loss of $89.1 million, or $0.29 per share. Excluding one-time items, it earned $2.15 per share.

Its revenue jumped to $2.06 billion. However, analysts were projecting a profit of $2.06 per share on revenue of $2.06 billion.

Valeant shares gained 1.94% to $149.14 in pre-market trading.

Posted-In: profitEarnings News

 

Related Articles (VRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters